Awards & Advancement

Blade Therapeutics appoints Dr. Maria E. Fuentes EVP, Research

Tuesday, August 22, 2017

Blade Therapeutics, a private biopharmaceutical company advancing novel anti-fibrotic therapies to meet important patient needs, announced the appointment of Maria E. Fuentes, Ph.D., as Executive Vice President, Research. In this newly established position, Dr. Fuentes will lead Blade’s anti-fibrotic programs in preclinical testing. Blade’s flagship program, focused on a small molecule cysteine protease inhibitor, is expected to enter IND-enabling studies by year-end 2017.

[Read More]

PPD’s Susan Atkinson recognized by PharmaVOICE

Tuesday, August 15, 2017

Pharmaceutical Product Development (PPD) announced that Susan Atkinson, Ph.D., senior vice president of global biometrics for PPD, has been named to the 2017 PharmaVOICE 100 list of the most inspiring people in the life sciences industry.

[Read More]

WCG’s MedAvante-ProPhase expands executives

Tuesday, August 15, 2017

WIRB-Copernicus Group (WCG), a provider of solutions that measurably improve the quality and efficiency of clinical research, announced that industry experts Steven Herne and Michael Cioffi have joined the leadership of MedAvanteProPhase, the Group’s electronic clinical outcomes assessment (eCOA) arm. Herne and Cioffi are tasked with expanding MedAvante-ProPhase’s already formidable portfolio of services and technologies, which improve the quality of clinical trial data collection and analysis in the fields of CNS and mental health.

[Read More]

Iovance Biotherapeutics appoints Timothy Morris CFO

Thursday, August 10, 2017

Iovance Biotherapeutics, a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, announced the appointment of Timothy E. Morris as Chief Financial Officer of the company, effective August 14, 2017. Morris has over 30 years of strategic financial and operating experience in the biotechnology sector.

[Read More]

Two Parexel executives named to 2017 PharmaVOICE 100

Thursday, August 3, 2017

Parexel International, a global biopharmaceutical services provider, announced that Sy Pretorius, M.D., Senior Vice President and Chief Scientific Officer, and Evan Demestihas, M.D., RPh, Vice President, Worldwide Head of The Medical Affairs Company (TMAC), have been named to PharmaVOICE magazine’s list of the 100 most inspiring people in the life sciences industry. The honor, published in the July/August 2017 issue of PharmaVOICE, recognizes both leaders for their valuable contributions to the industry and dedication to improving patients’ lives, while also mentoring the next generation of industry leaders.

[Read More]